CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Access TeleCare

Access TeleCare is a leading national provider of acute telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, and value-based care organizations since 2004. The company provides a supportive and d...

Honors Holdings

Honors Holdings, LLC is a leading franchisee of Orangetheory Fitness studios globally.

SonarMD

SonarMD provides care management for complex chronic conditions that use high-cost drugs. Through enhanced patient engagement, care coordination, and specialty pharmacy optimization, we improve the experience for both patients and clinical teams.

Novocardia

Novocardia is on a mission to transform how cardiovascular disease care is delivered in the United States, and aims to help patients with heart and vascular disease live longer, healthier, and more satisfying lives. We are committed to putting cardiologists, and their patients, at the center of care by investing in our partner practices, deploying purpose-built data and analytics tools to improve patient outcomes, and enabling our partners to transition more successfully to value-based care.

Pathology Solutions

Pathology Solutions is a Eatontown, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.